Table 3.
Multivariate analyses of outcomes
| Group | Total | Outcomes | OR (95%CI) | P value |
|---|---|---|---|---|
| (n=730) | Recent evaluation by retina specialist (n=167; 22.9%) * | |||
| No PPS | 299 | 66 (22.1%) | Reference | |
| T1 | 158 | 23 (14.6%) | 0.70 (0.39, 1.20) | 0.21 |
| T2 | 131 | 23 (17.6%) | 0.70 (0.40, 1.18) | 0.20 |
| T3 | 142 | 55 (38.7%) | 1.99 (1.26, 3.14) | 0.003 |
| (n=623) | AMD+ (n=116, 18.6%) * | |||
| No PPS | 243 | 37 (15.2%) | Reference | |
| T1 | 138 | 19 (13.8%) | 1.37 (0.73, 2.51) | 0.32 |
| T2 | 118 | 20 (16.9%) | 1.14 (0.62, 2.05) | 0.68 |
| T3 | 124 | 40 (32.3%) | 2.41 (1.44, 4.03) | <0.001 |
| (n=765) | Overall eyesight score <3 (n=49; 6.4%) † | |||
| No PPS | 313 | 19 (6.0%) | Reference | |
| T1 | 161 | 10 (6.2%) | 1.00 (0.42, 2.27) | 0.98 |
| T2 | 140 | 6 (4.3%) | 0.75 (0.29, 1.78) | 0.54 |
| T3 | 151 | 14 (9.3%) | 1.85 (0.87, 3.87) | 0.10 |
| (n=764) | Reading small print score <3 (n=57; 7.5%) † | |||
| No PPS | 311 | 20 (6.4%) | Reference | |
| T1 | 161 | 6 (3.7%) | 0.71 (0.25, 1.75) | 0.48 |
| T2 | 140 | 11 (7.9%) | 1.23 (0.55, 2.64) | 0.60 |
| T3 | 152 | 20 (13.2%) | 2.29 (1.15, 4.57) | 0.02 |
| (n=743) | Driving at night score <3 (n=160; 21.5%)⸸ | |||
| No PPS | 301 | 62 (20.6%) | Reference | |
| T1 | 158 | 32 (22.2%) | 1.02 (0.61, 1.69) | 0.94 |
| T2 | 137 | 28 (20.0%) | 1.25 (0.77, 2.01) | 0.37 |
| T3 | 147 | 38 (25.9%) | 1.33 (0.82, 2.15) | 0.24 |
| (n=764) | Reading menus in dim lighting score <3 (n=112, 14.7%) ‡ | |||
| No PPS | 311 | 40 (12.9%) | Reference | |
| T1 | 161 | 15 (9.3%) | 0.90 (0.46, 1.69) | 0.75 |
| T2 | 140 | 28 (20.0%) | 1.67 (0.97, 2.87) | 0.06 |
| T3 | 152 | 29 (19.1%) | 1.48 (0.84, 2.58) | 0.16 |
| (n=737) | VFQ <12 (n=113; 15.3%) † | |||
| No PPS | 298 | 43 (14.4%) | Reference | |
| T1 | 156 | 13 (8.3%) | 0.65 (0.32, 1.22) | 0.20 |
| T2 | 137 | 24 (17.5%) | 1.16 (0.66, 2.00) | 0.59 |
| T3 | 146 | 33 (22.6%) | 1.66 (0.98, 2.80) | 0.06 |
AMD+: Age-related macular degeneration and any pigmentary maculopathy.
Adjusted for age, race, gender, and smoking status.
Adjusted for age, race, gender, smoking status, and history of splenic disease.
Adjusted for age, race, gender, smoking status, and history of kidney disease.
Adjusted for age, race, gender, smoking status, BMI, and history of splenic disease.